Lv11
80 积分 2026-01-27 加入
Carfilzomib–lenalidomide–dexamethasone versus lenalidomide–dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial
6小时前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
2个月前
已完结
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
2个月前
已完结
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS
3个月前
已完结
意义未明的单克隆免疫球蛋白血症和冒烟型多发性骨髓瘤全程管理中国专家共识（2025年版）
3个月前
已完结
Zur vegetativen Regulation der Serumphosphatide beim Menschen
3个月前
已关闭
The inter‐rater and intra‐rater reliability of a recently developed equation to determine liver volume using three simple two‐dimensional ultrasound measurements
3个月前
已完结
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
4个月前
已完结
Systemic Amyloidosis Recognition, Prognosis, and Therapy
4个月前
已完结
Immunotherapy in AL Amyloidosis
4个月前
已完结
皖公网安备34019202002308
